Abbott India Limited | ABBOTINDIA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 10,909 | 10,314 | 16,843 | 21,974 | 24,090 |
Short-term investment |
| 0 | 343 | 0 | 0 | 0 |
Accounts receivables |
| 1,762 | 2,634 | 2,761 | 3,179 | 2,502 |
Inventories |
| 5,006 | 5,853 | 6,068 | 5,272 | 7,176 |
Deferred income taxes |
| 132 | 157 | 70 | 269 | 311 |
Other current assets |
| 1,121 | 3,353 | 1,868 | 1,353 | 1,106 |
Total current assets |
| 18,930 | 22,655 | 27,610 | 32,046 | 35,185 |
Gross property plant... |
| 1,077 | 786 | 1,031 | 1,002 | 1,037 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 1,077 | 786 | 1,031 | 1,002 | 1,037 |
Work in Progress |
| 51 | 22 | 7 | 16 | 7 |
Miscellaneous Investment |
| 56 | 150 | 161 | 168 | 466 |
Deferred income taxes |
| 124 | 146 | 131 | 144 | 178 |
Intangible assets |
| 31 | 28 | 19 | 9 | 12 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 390 | 375 | 451 | 2,082 | 1,520 |
Total non-current assets |
| 1,728 | 1,507 | 1,799 | 3,422 | 3,219 |
Total assets |
| 20,658 | 24,162 | 29,409 | 35,468 | 38,405 |
Short-term debt |
| 0 | 0 | 0 | 0 | 0 |
Accounts Payable... |
| 4,747 | 4,806 | 6,635 | 6,578 | 7,627 |
Provisions |
| 704 | 775 | 953 | 1,074 | 1,160 |
Taxes Payable |
| 87 | 282 | 86 | 76 | 155 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 357 | 349 |
Other current liabilities |
| 779 | 818 | 894 | 826 | 1,019 |
Total current liabilities |
| 6,316 | 6,681 | 8,569 | 8,911 | 10,309 |
Long-term debt |
| 0 | 0 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 0 | 0 | 0 | 0 | 0 |
Provisions |
| 472 | 553 | 754 | 848 | 898 |
Capital Leases |
| 0 | 0 | 0 | 1,392 | 1,177 |
Other longterm liabilities |
| 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities |
| 472 | 553 | 754 | 2,240 | 2,074 |
Total liabilities |
| 6,789 | 7,234 | 9,323 | 11,151 | 12,383 |
Share Capital |
| 212 | 212 | 212 | 212 | 213 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 13,657 | 16,715 | 19,873 | 24,105 | 25,809 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 13,869 | 16,928 | 20,086 | 24,317 | 26,022 |
Total Liabilities and Equity |
| 20,658 | 24,162 | 29,409 | 35,468 | 38,405 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |